Uniprot_ID	Protein_Name	Entry_Name	Tot_Num_Drugs	Gene_Name	Gene_ID	PDB	Pathways_ID	Pathways_Name	GO_Function	GO_Process	GO_Component	Confidence_Score	PDB_dt
P19793	Retinoic acid receptor RXR-alpha	RXRA_HUMAN	21	RXRA	6256	1BY4;1DSZ;1FBY;1FM6;1FM9;1G1U;1G5Y;1K74;1LBD;1MV9;1MVC;1MZN;1R0N;1RDT;1RXR;1XLS;1XV9;1XVP;1YNW;2ACL;2NLL;2P1T;2P1U;2P1V;2ZXZ;2ZY0;3DZU;3DZY;3E00;3E94;3FAL;3FC6;3FUG;3H0A;3KWY;3NSP;3NSQ;3OAP;3OZJ;3PCU;3R29;3R2A;3R5M;3UVV;4CN2;4CN3;4CN5;4CN7;4J5W;4J5X;4K4J;4K6I;4M8E;4M8H;4N5G;4N8R;4NQA;4OC7;4POH;4POJ;4PP3;4PP5;4RFW;4RMC;4RMD;4RME;4ZO1	hsa03320|hsa04151|hsa04659|hsa04919|hsa04920|hsa04928|hsa04932|hsa04976|hsa05160|hsa05200|hsa05202|hsa05216|hsa05222|hsa05223|hsa05226	PPAR signaling pathway|PI3K-Akt signaling pathway|Th17 cell differentiation|Thyroid hormone signaling pathway|Adipocytokine signaling pathway|Parathyroid hormone synthesis, secretion and action|Non-alcoholic fatty liver disease (NAFLD)|Bile secretion|Hepatitis C|Pathways in cancer|Transcriptional misregulation in cancer|Thyroid cancer|Small cell lung cancer|Non-small cell lung cancer|Gastric cancer	zinc ion binding|9-cis retinoic acid receptor activity|steroid hormone receptor activity|retinoic acid-responsive element binding|DNA binding|RNA polymerase II regulatory region sequence-specific DNA binding|chromatin DNA binding|vitamin D receptor binding|retinoic acid receptor activity|transcription factor activity, sequence-specific DNA binding|enzyme binding|RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding|sequence-specific DNA binding|protein heterodimerization activity|transcription coactivator activity	protein homotetramerization|positive regulation of translational initiation by iron|response to vitamin A|response to vitamin D|small molecule metabolic process|response to glucocorticoid|regulation of branching involved in prostate gland morphogenesis|midgut development|retinoic acid receptor signaling pathway|transcription initiation from RNA polymerase II promoter|negative regulation of transcription from RNA polymerase II promoter|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development|in utero embryonic development|cellular response to insulin stimulus|ventricular cardiac muscle cell differentiation|response to retinoic acid|cellular lipid metabolic process|ventricular cardiac muscle tissue morphogenesis|axon regeneration|cholesterol metabolic process|embryo implantation|positive regulation of apoptotic process|bile acid and bile salt transport|regulation of myelination|inflammatory response|negative regulation of cell proliferation|maternal placenta development|liver development|positive regulation of transcription from RNA polymerase II promoter|modulation by virus of host morphology or physiology|response to ethanol|camera-type eye development|peroxisome proliferator activated receptor signaling pathway|aging|bile acid metabolic process|vitamin metabolic process|positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus|response to selenium ion|gene expression	nuclear chromatin|nucleus|nucleoplasm|receptor complex|axon|RNA polymerase II transcription factor complex	1	NA
Q15596	Nuclear receptor coactivator 2	NCOA2_HUMAN	30	NCOA2	10499	1GWQ;1GWR;1M2Z;1MV9;1MVC;1MZN;1P93;1T63;1T65;1UHL;1YOK;1ZDT;1ZDU;1ZKY;2AO6;2B1V;2B1Z;2B23;2FAI;2G44;2G5O;2LDC;2P15;2P1T;2P1U;2P1V;2Q7J;2Q7L;2YJD;2ZXZ;2ZY0;3A9E;3CLD;3DZU;3DZY;3E00;3E7C;3E94;3ERD;3FUG;3GN8;3K22;3K23;3KWY;3KYT;3L0E;3L0J;3L0L;3O1D;3O1E;3OAP;3OZJ;3PCU;3PLZ;3Q95;3Q97;3R5M;3UP0;3UP3;4CSJ;4DOS;4E2J;4FHH;4FHI;4IA1;4IA2;4IA3;4IA7;4IQR;4IU7;4IUI;4IV2;4IV4;4IVW;4IVY;4IW6;4IW8;4IWC;4IWF;4K4J;4K6I;4M8E;4M8H;4NIE;4NQA;4OC7;4P6W;4P6X;4POH;4POJ;4PP3;4PP5;4PP6;4PPP;4PPS;4PXM;4Q0A;4QE6;4QE8;4RFW;4RMC;4RMD;4RME;4RUO;4WG0;4ZN9;4ZO1	hsa04915|hsa04919	Estrogen signaling pathway|Thyroid hormone signaling pathway	ligand-dependent nuclear receptor binding|RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding|chromatin binding|histone acetyltransferase activity|thyroid hormone receptor coactivator activity|transcription coactivator activity|RNA polymerase II core promoter proximal region sequence-specific DNA binding|ligand-dependent nuclear receptor transcription coactivator activity|nuclear hormone receptor binding	chromatin organization|cellular lipid metabolic process|transcription, DNA-templated|intracellular receptor signaling pathway|small GTPase mediated signal transduction|bile acid metabolic process|bile acid and bile salt transport|cellular response to Thyroglobulin triiodothyronine|small molecule metabolic process|regulation of glucose metabolic process|locomotor rhythm|regulation of transcription, DNA-templated|circadian regulation of gene expression|positive regulation of transcription from RNA polymerase II promoter|cellular response to hormone stimulus|negative regulation of transcription from RNA polymerase II promoter	cytoplasm|nucleus|nucleoplasm	1	NA
P37231	Peroxisome proliferator-activated receptor gamma	PPARG_HUMAN	73	PPARG	5468	1FM6;1FM9;1I7I;1K74;1KNU;1NYX;1PRG;1RDT;1WM0;1ZEO;1ZGY;2ATH;2F4B;2FVJ;2G0G;2G0H;2GTK;2HFP;2HWQ;2HWR;2I4J;2I4P;2I4Z;2OM9;2P4Y;2POB;2PRG;2Q59;2Q5P;2Q5S;2Q61;2Q6R;2Q6S;2Q8S;2QMV;2VSR;2VST;2VV0;2VV1;2VV2;2VV3;2VV4;2XKW;2YFE;2ZK0;2ZK1;2ZK2;2ZK3;2ZK4;2ZK5;2ZK6;2ZNO;2ZVT;3ADS;3ADT;3ADU;3ADV;3ADW;3ADX;3AN3;3AN4;3B0Q;3B0R;3B1M;3B3K;3BC5;3CDP;3CDS;3CS8;3CWD;3D6D;3DZU;3DZY;3E00;3ET0;3ET3;3FEJ;3FUR;3G9E;3GBK;3H0A;3HO0;3HOD;3IA6;3K8S;3KMG;3LMP;3NOA;3OSI;3OSW;3PBA;3PO9;3PRG;3QT0;3R5N;3R8A;3R8I;3S9S;3SZ1;3T03;3TY0;3U9Q;3V9T;3V9V;3V9Y;3VJH;3VJI;3VN2;3VSO;3VSP;3WJ4;3WJ5;3WMH;3X1H;3X1I;4A4V;4A4W;4CI5;4E4K;4E4Q;4EM9;4EMA;4F9M;4FGY;4HEE;4JAZ;4JL4;4L96;4L98;4O8F;4OJ4;4PRG;4PVU;4PWL;4R2U;4R6S;4XLD;4XTA;4XUM;4Y29	hsa03320|hsa04152|hsa04211|hsa04380|hsa04714|hsa05016|hsa05200|hsa05202|hsa05216	PPAR signaling pathway|AMPK signaling pathway|Longevity regulating pathway|Osteoclast differentiation|Thermogenesis|Huntington disease|Pathways in cancer|Transcriptional misregulation in cancer|Thyroid cancer	drug binding|zinc ion binding|ligand-dependent nuclear receptor transcription coactivator activity|core promoter sequence-specific DNA binding|transcription factor activity, sequence-specific DNA binding|RNA polymerase II regulatory region DNA binding|prostaglandin receptor activity|transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding|steroid hormone receptor activity|transcription regulatory region DNA binding|DNA binding|RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding|chromatin binding|activating transcription factor binding|alpha-actinin binding|enzyme binding|arachidonic acid binding|retinoid X receptor binding	regulation of transcription involved in cell fate commitment|cellular response to retinoic acid|response to cold|cellular response to insulin stimulus|regulation of circadian rhythm|negative regulation of collagen biosynthetic process|response to vitamin A|monocyte differentiation|cellular response to hyperoxia|cellular response to vitamin E|negative regulation of cell growth|negative regulation of cholesterol storage|organ regeneration|negative regulation of pancreatic stellate cell proliferation|gene expression|activation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of transcription, DNA-templated|signal transduction|negative regulation of macrophage derived foam cell differentiation|cellular response to prostaglandin E stimulus|negative regulation of telomerase activity|transcription initiation from RNA polymerase II promoter|lipoprotein transport|response to low-density lipoprotein particle|lipid homeostasis|positive regulation of fatty acid oxidation|placenta development|response to caffeine|low-density lipoprotein particle receptor biosynthetic process|heart development|positive regulation of fat cell differentiation|regulation of cholesterol transporter activity|response to retinoic acid|response to starvation|negative regulation of interferon-gamma-mediated signaling pathway|positive regulation of transcription from RNA polymerase II promoter|response to immobilization stress|peroxisome proliferator activated receptor signaling pathway|response to metformin|positive regulation of sequence-specific DNA binding transcription factor activity|negative regulation of acute inflammatory response|negative regulation of receptor biosynthetic process|lipid metabolic process|positive regulation of oligodendrocyte differentiation|negative regulation of smooth muscle cell proliferation|response to diuretic|glucose homeostasis|negative regulation of sequestering of triglyceride|G-protein coupled receptor signaling pathway|response to mechanical stimulus|response to lipid|long-chain fatty acid transport|negative regulation of transcription, DNA-templated|white fat cell differentiation|cellular response to lithium ion|rhythmic process|response to nutrient|epithelial cell differentiation|brown fat cell differentiation|response to estrogen|cell maturation|cell fate commitment|innate immune response|diet induced thermogenesis|negative regulation of transcription from RNA polymerase II promoter|positive regulation of phagocytosis, engulfment|fatty acid oxidation|regulation of blood pressure	Golgi apparatus|intracellular membrane-bounded organelle|RNA polymerase II transcription factor complex|cytosol|nucleus|nucleoplasm|perinuclear region of cytoplasm	1	NA